Skip to content
Clinical Trials – home
SloveniaBack to Slovenia

Clinical trials in Ljubljana – page 4

92 clinical trials in Ljubljana, Slovenia across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

SloveniaOur site in SloveniaKlinicnaPreskusanja.si(opens in a new tab)
Ljubljana at a glance
92
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

92 trials in Ljubljana

Open in trial search
Countries:SloveniaSlovenia
  • Participants:18–64 years · 65+ years
  • Substances:ABBV-8736
  • Sponsor:AbbVie Deutschland GmbH & Co. KG
Countries:SloveniaSlovenia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:SloveniaSlovenia
  • Participants:0–17 years · 18–64 years
  • Substances:Blinatumomab
  • Sponsor:Charite Universitaetsmedizin Berlin KöR
Registered drug
Countries:SloveniaSlovenia
  • Participants:18–64 years · 65+ years
  • Substances:Masitinib
  • Sponsor:Ab Science
Countries:SloveniaSlovenia
  • Participants:18–64 years
  • Substances:Ocrelizumab
  • Sponsor:Amgen Inc.
Countries:SloveniaSlovenia
  • Participants:18–64 years · 65+ years
  • Substances:Duloxetine
  • Sponsor:European Organisation For Research And Treatment Of Cancer
Countries:SloveniaSlovenia
  • Participants:18–64 years · 65+ years
  • Substances:Adalimumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG
Countries:SloveniaSlovenia
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:Novartis Pharma AG
Countries:SloveniaSlovenia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Efmoroctocog Alfa
  • Sponsor:Swedish Orphan Biovitrum AB (publ)
Registered drug
Countries:SloveniaSlovenia
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Novo Nordisk A/S
Countries:SloveniaSlovenia
  • Participants:18–64 years · 65+ years
  • Substances:Dazodalibep
  • Sponsor:Horizon Therapeutics Ireland Designated Activity Company
Countries:SloveniaSlovenia
  • Participants:18–64 years · 65+ years
  • Substances:Dazodalibep
  • Sponsor:Horizon Therapeutics Ireland Designated Activity Company

Other cities in Slovenia

The busiest research cities in the country

All 17 cities in Slovenia

Clinical research in Ljubljana

What the registry says about research in the country

01 Autoimmune Conditions

Innovative research focusing on Sjögren's Syndrome and inflammatory bowel conditions, including studies evaluating novel therapeutic approaches for Crohn's Disease and Ulcerative Colitis.

  • Dazodalibep safety trials
  • Combination therapy assessments
  • Advanced treatment protocols

Multiple studies investigating long-term effectiveness and patient outcomes in chronic inflammatory conditions.

02 Cardiovascular Research

Comprehensive studies addressing cardiovascular disease and related conditions, including research on lipoprotein management and cardiac inflammation treatments.

  • Lipid-lowering therapies
  • Acute myocarditis treatment
  • Pulmonary embolism management

Focus on preventive measures and innovative therapeutic approaches for various cardiac conditions.

03 Oncology Studies

Advanced research in cancer treatment, including studies on breast cancer, melanoma, and various blood cancers.

  • Endocrine therapy optimization
  • Immunotherapy combinations
  • Leukemia treatment protocols

Emphasis on personalized treatment approaches and improved patient outcomes.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.